SBIR/STTR Research Award
Standard-issue Antimicrobial Combat Burn Gauze
Award amount
$2,195,570Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2022Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- IFYBER LLC
- Proposal award date
- 2022-05-16
- Contract end date
- 2024-11-24
- UEI
- SWJHU7YPRAU9
- Solicitation number
- 20.1
- Topic code
- DHA201-D001
Research abstract
The purpose of the continuation of this Direct-to-Phase II effort is to develop a field-expedient, antimicrobial, hydration-providing wound dressing for acute care of large burn wounds.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Advancement of a Cu-CMC nonwoven dressing for burns and expansion of the Cu-CMC platform
- Rapid field testing of field water samples for total coliform and E. coli using isothermal amplification and unique micron-sized particles for cell capture and concentration
- Development of wound care formulations for PVP/NO: A novel nitric oxide releasing platform with potent antimicrobial and anti-biofilm properties
- Development of Novel Broad Spectrum Antimicrobial Corneal Tissue Storage Solutions
- Peptide based wound dressing for prevention and management of infected wounds
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Succor Combat Foam for Large Burn Wounds
- Deployable Wound Care Products to Decrease Preventable Death Outcomes by Mitigating Infection on Battlefield and through Long Term Care
- Deployable Wound Care Products to Decrease Preventable Death Outcomes by Mitigating Infection on Battlefield and through Long Term Care
- Succor Combat Foam for Large Burn Wounds
Research funding history
16 SBIR/STTR records share this UEI (2009–2025). Reported award amounts total $6,586,065. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services, National Science Foundation